Identification and characterization of OGG1 mutations in patients with Alzheimer's disease

Guogen Mao; Xiaoyu Pan; Bei Bei Zhu; Yanbin Zhang; Fenghua Yuan; Jian Huang; Mark A. Lovell; Maxwell P. Lee; William R. Markesbery; Guo Min Li; Liya Gu

doi:10.1093/nar/gkm189

Identification and characterization of OGG1 mutations in patients with Alzheimer's disease

Guogen Mao, Xiaoyu Pan, Bei Bei Zhu, Yanbin Zhang, Fenghua Yuan, Jian Huang, Mark A. Lovell, Maxwell P. Lee, William R. Markesbery, Guo Min Li, Liya Gu

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Abstract

Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C₇₉₆) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C₇₉₆-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.

Original language	English
Pages (from-to)	2759-2766
Number of pages	8
Journal	Nucleic Acids Research
Volume	35
Issue number	8
DOIs	https://doi.org/10.1093/nar/gkm189
State	Published - Apr 2007

Bibliographical note

Funding Information:
We thank Drs Sankar Mitra and Tapas Hazra for the human OGG1 expression vector. This work was supported by a program project grant (P01 AG05119) and an Alzheimer’s Disease Center Grant (1P30 AG0 28383) from the National Institute on Aging. X.P. was supported by a pre-doctoral fellowship from China Scholarship Council. G.M.L. is the James-Gardner Endowed Chair in Cancer Research, and W.R.M. is the Commonwealth Endowed Chair in Aging. Funding to pay the Open Access publication charges for this article was provided by the James F. Madeline and Edith D. Gardner Endowment to G.M.L.

ASJC Scopus subject areas

Genetics

Access to Document

10.1093/nar/gkm189

Cite this

@article{3d1afb3b2962420fa566b20b84a0b396,

title = "Identification and characterization of OGG1 mutations in patients with Alzheimer's disease",

abstract = "Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C796) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C796-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.",

author = "Guogen Mao and Xiaoyu Pan and Zhu, {Bei Bei} and Yanbin Zhang and Fenghua Yuan and Jian Huang and Lovell, {Mark A.} and Lee, {Maxwell P.} and Markesbery, {William R.} and Li, {Guo Min} and Liya Gu",

note = "Funding Information: We thank Drs Sankar Mitra and Tapas Hazra for the human OGG1 expression vector. This work was supported by a program project grant (P01 AG05119) and an Alzheimer{\textquoteright}s Disease Center Grant (1P30 AG0 28383) from the National Institute on Aging. X.P. was supported by a pre-doctoral fellowship from China Scholarship Council. G.M.L. is the James-Gardner Endowed Chair in Cancer Research, and W.R.M. is the Commonwealth Endowed Chair in Aging. Funding to pay the Open Access publication charges for this article was provided by the James F. Madeline and Edith D. Gardner Endowment to G.M.L.",

year = "2007",

month = apr,

doi = "10.1093/nar/gkm189",

language = "English",

volume = "35",

pages = "2759--2766",

number = "8",

}

TY - JOUR

T1 - Identification and characterization of OGG1 mutations in patients with Alzheimer's disease

AU - Mao, Guogen

AU - Pan, Xiaoyu

AU - Zhu, Bei Bei

AU - Zhang, Yanbin

AU - Yuan, Fenghua

AU - Huang, Jian

AU - Lovell, Mark A.

AU - Lee, Maxwell P.

AU - Markesbery, William R.

AU - Li, Guo Min

AU - Gu, Liya

N1 - Funding Information: We thank Drs Sankar Mitra and Tapas Hazra for the human OGG1 expression vector. This work was supported by a program project grant (P01 AG05119) and an Alzheimer’s Disease Center Grant (1P30 AG0 28383) from the National Institute on Aging. X.P. was supported by a pre-doctoral fellowship from China Scholarship Council. G.M.L. is the James-Gardner Endowed Chair in Cancer Research, and W.R.M. is the Commonwealth Endowed Chair in Aging. Funding to pay the Open Access publication charges for this article was provided by the James F. Madeline and Edith D. Gardner Endowment to G.M.L.

PY - 2007/4

Y1 - 2007/4

N2 - Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C796) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C796-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.

AB - Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C796) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C796-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.

UR - http://www.scopus.com/inward/record.url?scp=34250350823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250350823&partnerID=8YFLogxK

U2 - 10.1093/nar/gkm189

DO - 10.1093/nar/gkm189

M3 - Article

C2 - 17426120

AN - SCOPUS:34250350823

SN - 0305-1048

VL - 35

SP - 2759

EP - 2766

JO - Nucleic Acids Research

JF - Nucleic Acids Research

IS - 8

ER -

Identification and characterization of OGG1 mutations in patients with Alzheimer's disease

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this